A primary driver of high spending in the US health care system, relative to other countries, is the higher prices paid for health care in the United States. Part of what sustains these high prices is that health care prices are largely opaque.1,2 The goal of price transparency is to empower patients with new information so they can consider prices, along with quality, when making choices about when and where to receive health care. Ideally, such informed decision making would increase competition in the health care system, which in turn, would create incentives to lower prices or demonstrate value.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Sinaiko AD. What Is the Value of Market-Wide Health Care Price Transparency? JAMA. 2019;322(15):1449–1450. doi:10.1001/jama.2019.11578
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: